Global High Throughput Screening (HTS) Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the High Throughput Screening (HTS) market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the High Throughput Screening (HTS) market."
High-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. High-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry.
High throughput screening, also known as high content screening (HCS), is mainly used for conducting various genetic, chemical, and pharmacological tests that aid the drug discovery process starting from drug design to drug trails and other drug interactions. This process involves control software, various devices to handle liquids, and other detectors, which help to rapidly identify active compounds, genetic interactions, and other biomolecular interactions.

The global High Throughput Screening (HTS) market is valued at 14800 million US$ in 2018 is expected to reach 26800 million US$ by the end of 2025, growing at a CAGR of 7.7% during 2019-2025.
This report focuses on High Throughput Screening (HTS) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Throughput Screening (HTS) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Agilent Technologies, Inc.
    Danaher Corporation
    Thermofisher Scientific, Inc.
    PerkinElmer, Inc.
    Tecan Group Ltd.
    Merck Millipore
    Bio-Rad Laboratories
    Hamilton Company
    Axxam S.p.A.
    Aurora Biomed

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    By technology
        Cell-based Assays
        3D-Cell Cultures
        Ultra High Throughput
    By type
        Reagent
        Instruments
        Software
        Service

Segment by Application
    Drug discovery programs
    Chemical biology programs
    Biochemical screening
    Cell- & organ-based screening